Alpha 1 Antitrypsin Deficiency (cont.)
How common is alpha-1 antitrypsin deficiency?
Alpha-1 antitrypsin deficiency occurs worldwide, but its
prevalence varies by
population. For example, in Scandinavia this disorder affects 1 in 1,500 to
3,000 individuals, but it is less common in Asian and black populations. In
North America, alpha-1 antitrypsin deficiency affects 1 in 5,000 to 7,000
people.
What genes are related to alpha-1 antitrypsin deficiency?
Mutations in the SERPINA1 gene cause alpha-1 antitrypsin deficiency.
The SERPINA1 gene provides instructions for making a protein called alpha-1
antitrypsin. This protein protects the body from being damaged by a powerful
enzyme called neutrophil elastase. Neutrophil
elastase is released from white blood cells to fight infection, but it can
attack normal tissues (such as lung tissue) if not carefully controlled by
alpha-1 antitrypsin. Mutations in the SERPINA1 gene can lead to a shortage
(deficiency) of alpha-1 antitrypsin protein or an abnormal form of the protein
that cannot control neutrophil elastase. Uncontrolled, neutrophil elastase
destroys alveoli, which can lead to emphysema. The abnormal form of alpha-1
antitrypsin can also accumulate in the liver and may damage this organ.
How do people inherit alpha-1 antitrypsin deficiency?
This condition is inherited in an autosomal codominant
pattern. Codominance means that two different versions of the gene may be
expressed, and both versions contribute to the genetic trait.
The most common version (allele) of the SERPINA1 gene, called M, produces
normal levels of the alpha-1 antitrypsin protein. Most people have two copies of
the M allele (MM) in each cell. Other versions of the SERPINA1 gene lead to
reduced levels of alpha-1 antitrypsin. For example, the S allele produces
moderately low levels of this enzyme, and the Z allele produces very little
alpha-1 antitrypsin. Individuals with two copies of the Z allele (ZZ) in each
cell are likely to have alpha-1 antitrypsin deficiency. Those with the SZ
combination have an increased risk of developing lung disorders (such as
emphysema), particularly if they smoke.
Worldwide, about 161 million people have one copy of the S or Z allele and
one copy of the M allele in each cell (MS or MZ). Individuals with a MS (or SS)
combination usually produce enough alpha-1 antitrypsin to protect the lungs.
People with MZ alleles, however, have a slightly increased risk of impaired lung
or liver function.
Next: Where can I find information about treatment for alpha-1 antitrypsin
deficiency? »
- alpha-1-proteinase inhibitor-injection, Prolastin - Consumer information about the medication ALPHA-1-PROTEINASE INHIBITOR - INJECTION (Prolastin), includes side effects, drug interactions, recommended dosages, and storage information. Read more about the prescription drug ALPHA-1-PROTEINASE INHIBITOR - INJECTION.
- Liver Blood Tests - Learn about liver blood tests used to detect liver damage disease such as fatty liver, cirrhosis, hepatitis, Tylenol liver damage, and more. This includes measuring the aminotransferases enzymes (AST and ALT levels)
- Cirrhosis (Liver) - Learn about cirrhosis of the liver symptoms including jaundice, fatigue, weakness, loss of appetite, itching, and easy bruising.
Latest Medical News
Lungs RSS